GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,934,000 | -8.7% | 8,373,637 | +21.4% | 0.00% | – |
| Q2 2016 | $3,215,000 | -65.0% | 6,898,520 | +2.3% | 0.00% | -100.0% |
| Q1 2016 | $9,173,000 | +8.2% | 6,744,883 | +16.9% | 0.00% | 0.0% |
| Q4 2015 | $8,479,000 | -94.6% | 5,768,046 | -63.0% | 0.00% | -83.3% |
| Q3 2015 | $157,367,000 | +1655.9% | 15,603,724 | +196.0% | 0.01% | +500.0% |
| Q2 2015 | $8,962,000 | +35.0% | 5,271,820 | +10.4% | 0.00% | – |
| Q1 2015 | $6,637,000 | +9.7% | 4,774,187 | +19.2% | 0.00% | – |
| Q4 2014 | $6,048,000 | -21.9% | 4,004,892 | +6.6% | 0.00% | -100.0% |
| Q3 2014 | $7,740,000 | -32.0% | 3,756,933 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $11,375,000 | +44.6% | 3,717,177 | +18.2% | 0.00% | 0.0% |
| Q1 2014 | $7,864,000 | -41.4% | 3,145,551 | +16.4% | 0.00% | 0.0% |
| Q4 2013 | $13,409,000 | +136.3% | 2,703,465 | +8.1% | 0.00% | 0.0% |
| Q3 2013 | $5,675,000 | +22.1% | 2,500,426 | +19.5% | 0.00% | – |
| Q2 2013 | $4,646,000 | – | 2,092,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |